Stock market disclosures have brought to light two deal-related developments in India. The first being that GMS Holdings has invested in biotech firm Stelis Biopharma, a part of drug firm Strides Shasun, and the other involved US firm GE’s Rs 1,926 crore open offer to acquire stake in Alstom T&D failing to take off.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com